Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

JNJ 102.18 +0.14 (0.14%)
price chart
Johnson & Johnson Reaches Settlement in 845 Levaquin Cases
Johnson & Johnson settled lawsuits with about 845 plaintiffs who claimed the drugmaker didn't properly warn of the risks of tendon damage from its antibiotic Levaquin.
J&J's Global Media Review Hits Halfway Mark
Johnson & Johnson is midway through a global review of its media planning and buying business with its decision in the North American market this week.
Warren Buffett Buys More Wells Fargo and IBM, Sells Johnson & Johnson
In the previous article we reported that Berkshire Hathaway bought into 4 new stocks and sold 3 old ones. As pointed by readers, most of those positions are not Warren Buffett's.
Warren Buffett Buys Deere and Wabco; Sells Johnson & Johnson and P&G  ValueWalk
Buffett's Berkshire Sells Most of J&J and GE Stakes
Johnson & Johnson Campaign for Nursing's Future turns 10
In response to this dire scenario, The Johnson & Johnson Campaign for Nursing's Future emerged in 2002. It had a number of highly ambitious goals, including improving the nursing profession's image, recruiting new nurses and retaining RNs already in ...
Dr. Buffett Has Diagnosed Johnson & Johnson As Too Big To Succeed
We are amazed that Johnson & Johnson's (NYSE:JNJ) shares have held up better than the S&P 500 over the last month.
Johnson & Johnson One-Ups Tuberculosis
In an 18-0 ruling on efficacy, the FDA advisory committee voted in favor of Johnson & Johnson's bedaquiline, a drug to combat multidrug-resistant tuberculosis.
Weldon passes baton at Johnson & Johnson to Gorsky
Johnson & Johnson Chairman Bill Weldon is stepping down from his role at the end of the year and being replaced by Chief Executive Alex Gorsky.
J&J CEO Gorsky elected chairman, replacing Weldon  Reuters
Buy Johnson & Johnson For Rock Solid Dividends - No Capital Appreciation Expected
Johnson & Johnson (NYSE:JNJ) operates under three segments: Pharmaceutical (eighth largest in the world), Medical Devices and Diagnostic (the largest in the world) and Consumer (6th largest in the world).
J&J says it won't enforce AIDS drug patent in Africa
LONDON Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson's HIV/AIDS drug Prezista for sale in Africa and other poor countries.
J&J says won't enforce AIDS drug patent in Africa  Livemint
J&J opens HIV fighter Prezista to copycats in poor countries  FiercePharma
Johnson & Johnson Settles 845 Levaquin Tendon Rupture Lawsuits
As a Texas medical doctor and Dallas Product Liability attorney, I am providing this update for folks who have been injured by the use of Levaquin and have suffered from severe tendon injuries.
J&J settles a boatload of Levaquin cases  FiercePharma